Bausch Health Companies Inc. (NYSE:BHC) Is Largely Controlled by Institutional Shareholders Who Own 56% of the Company
Bausch Health Companies Inc. (NYSE:BHC) Is Largely Controlled by Institutional Shareholders Who Own 56% of the Company
Key Insights
主要見解
- Given the large stake in the stock by institutions, Bausch Health Companies' stock price might be vulnerable to their trading decisions
- The top 9 shareholders own 51% of the company
- 12% of Bausch Health Companies is held by insiders
- 鑑於機構在股票中的大額持股,bausch health公司的股價可能會受到其交易決策的影響。
- 前9大股東擁有該公司51%的股份。
- bausch health公司的12%股份由內部人士持有。
A look at the shareholders of Bausch Health Companies Inc. (NYSE:BHC) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 56% ownership. Put another way, the group faces the maximum upside potential (or downside risk).
查看bausch health公司的股東(紐交所:BHC)可以告訴我們哪個群體最有權力。我們可以看到,機構在公司中擁有最大的股份,持股比例爲56%。換句話說,該集團面臨着最大的上行潛力(或下行風險)。
Since institutional have access to huge amounts of capital, their market moves tend to receive a lot of scrutiny by retail or individual investors. Therefore, a good portion of institutional money invested in the company is usually a huge vote of confidence on its future.
由於機構有許多資金,因此他們的市場走勢往往會受到零售或個人投資者的密切關注。因此,機構投資公司的良好部分通常是對其未來充滿信心的重要標誌。
In the chart below, we zoom in on the different ownership groups of Bausch Health Companies.
在下面的圖表中,我們仔細觀察了bausch health公司的不同持有群體。
What Does The Institutional Ownership Tell Us About Bausch Health Companies?
機構持有情況告訴我們關於bausch health公司的什麼?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。
As you can see, institutional investors have a fair amount of stake in Bausch Health Companies. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Bausch Health Companies' historic earnings and revenue below, but keep in mind there's always more to the story.
正如您所見,機構投資者在bausch health公司持有相當數量的股份。這可以表明該公司在投資社區中具有一定程度的可信度。然而,最好要小心依賴於機構投資者所帶來的所謂驗證。他們有時也會犯錯。當多個機構持有一隻股票時,總有風險存在於「擁擠交易」中。當這種交易出錯時,多個方面可能會爭相迅速賣出股票。在沒有增長曆史的公司中,這種風險更高。您可以在下面看到bausch health公司的歷史盈利和營業收入,但請記住,故事總是更復雜。
Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. It looks like hedge funds own 15% of Bausch Health Companies shares. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. The company's largest shareholder is Alexander Meruelo, with ownership of 9.9%. Icahn Capital LP is the second largest shareholder owning 9.4% of common stock, and GoldenTree Asset Management LP holds about 8.0% of the company stock.
機構投資者擁有超過50%的股份,因此他們可以共同強有力地影響董事會決策。看起來對沖基金擁有bausch health公司15%的股份。這很有趣,因爲對沖基金通常會非常活躍並且積極。許多人尋求中期催化劑來推動股價上漲。該公司的最大股東是亞歷山大·梅魯埃洛,擁有9.9%的股份。艾克漢資本公司是第二大股東,持有9.4%的普通股,而GoldenTree 資產管理公司持有約8.0%的公司股票。
We did some more digging and found that 9 of the top shareholders account for roughly 51% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.
我們進行了進一步的挖掘,並發現前9大股東持有該公司股份的51%左右,這意味着除了大股東外,還有一些小股東,從而在一定程度上平衡了彼此的利益。
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.
儘管研究公司的機構持股可以增加您的研究價值,但研究分析師的建議也是一個好習慣,以更深入地了解股票的預期表現。有相當數量的分析師關注該股,因此了解他們對未來的總體觀點可能很有用。
Insider Ownership Of Bausch Health Companies
bausch health公司的內部持股
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
雖然內部人員的精確定義可能具有主觀性,但幾乎所有人都認爲董事會成員是內部人員。管理層最終向董事會負責。然而,如果經理是創始人或CEO,那麼他們成爲執行董事會成員並不罕見。
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
我通常認爲內部人士持股是一件好事。但是,在某些情況下,它會使其他股東更難以對董事會的決定進行問責。
Our most recent data indicates that insiders own a reasonable proportion of Bausch Health Companies Inc.. It is very interesting to see that insiders have a meaningful US$339m stake in this US$2.9b business. Most would be pleased to see the board is investing alongside them. You may wish to access this free chart showing recent trading by insiders.
我們最近的數據表明,內部人士持有bausch health公司的合理股份。看到內部人士在這家29億美金的企業中擁有33900萬美元的重大股份非常有趣。大多數人會很高興看到董事會與他們一起投資。您可能希望訪問這張顯示內部人士最近交易的免費圖表。
General Public Ownership
一般大衆所有權
With a 18% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Bausch Health Companies. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
公衆的持股比例爲18%,大多數由個人投資者組成,他們對bausch health公司具有一定程度的影響力。儘管這樣的持股比例可能不足以影響政策決策,但他們仍然可以對公司政策產生集體影響。
Next Steps:
下一步:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Be aware that Bausch Health Companies is showing 1 warning sign in our investment analysis , you should know about...
我認爲了解誰真正擁有一家公司的情況非常有趣。但要真正獲得洞察,我們還需要考慮其他信息。請注意,bausch health公司在我們的投資分析中顯示出一個警告信號,這是你需要知道的...
Ultimately the future is most important. You can access this free report on analyst forecasts for the company.
最終,未來最重要。您可以在這份關於該公司分析師預測的免費報告中獲取有關信息。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因